Apple, Meta, and Alphabet Face the AI Test in Q1 2026 Earnings
Apple, Meta, and Alphabet report Q1 2026 earnings this month. Here’s what Wall Street expects and why AI returns are the central question.
Apple, Meta, and Alphabet report Q1 2026 earnings this month. Here’s what Wall Street expects and why AI returns are the central question.
Gold touched nearly $5,000 per ounce in early 2026 before pulling back to $4,811. Here’s what’s driving the historic rally — and whether it can last.
US consumer confidence hit a record low in April 2026 as the Iran energy shock drives CPI to 3.3% and stagflation fears deepen across markets.
Bitcoin surged above $74,000 to a one-month high as US-Iran peace negotiations lifted risk appetite across crypto and equity markets. Here’s what it signals.
U.S. existing home sales fell 3.6% in March—far worse than the 0.7% consensus estimate. What the miss means for homebuilder stocks, REITs, and mortgage markets.
From protein folding to clinical trials, AI is transforming drug discovery. Novo Nordisk’s OpenAI deal is the latest signal for pharma investors.
From frozen IPOs to widening credit spreads, the US-China 145% tariff war is reshaping capital markets in ways not seen since the financial crisis.
Oracle and Bloom Energy are expanding their strategic partnership to deploy 2.8 GW of on-site fuel cell power for AI data centers, sending Oracle stock up 12.7%.
The Trump administration’s 100% pharmaceutical tariff threat is testing drug stock valuations, global supply chains, and corporate bond markets.
OpenAI’s private market valuation has ballooned to $852 billion, but some of its own backers are questioning the math as the company shifts strategic focus.